Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Search Icon
Search Icon
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Sort 92 results by:

Filter Applied. Clear All
Reset All Filters

Search Results for: Covid vacc

COVID-19, Nursing Homes, and the Need to Protect the Elderly

In early 2020 news began circulating that a life-threatening respiratory illness was sweeping across the world and had made its way to the United States. Reactions to the severity of the problem varied, but most jurisdictions seemed underprepared to deal with how COVID-19 would impact long-term care...

CLI Responds to Misinformation Regarding President Trump’s COVID-19 Treatment

“Uninformed commentary has emerged this morning stating that President Trump has received a medication created with the use of human embryonic stem cells.  CLI has reviewed the published information and our conclusion is straightforward: The president was not given any medicines to treat COVID-19...

Federal Bioethics Commissions and Bias Against the Unborn

In August, the Trump administration’s new Human Fetal Tissue Research Ethics Advisory Board reviewed requests made to the National Institutes of Health (NIH) for federally funded fetal tissue research. The Board recommended denying most of these requests.

Update: COVID-19 Vaccine Candidates and Abortion-Derived Cell Lines

Accurate information about the development and production of COVID-19 vaccines is essential, especially because many proposed candidates use newer molecular technologies for production of a viral vaccine.  One concern regarding the ethical assessment of viral vaccine candidates is the potential use...

New Abortion Trends in the United States: A First Look

To allow for a preliminary view of the current state of abortion in the U.S., the Charlotte Lozier Institute (CLI) reviewed all available state reports for 2017 and 2018. As of July 2020, 38 states had released 2018 abortion statistics. CLI’s preliminary review of 2017 state abortion reporting, pu...

A Policy and Funding Evaluation Of Human Fetal Tissue Research

Here we evaluate the actions and policy changes made by the Trump administration that have been taken since his term in office and analyze the current standing of federal funds used to support fetal tissue research.  First, we give a brief overview of how federal tax dollars are used to fund medica...

FDA’s Race to Defend Women From Dangerous Drugs

Abortion advocates—seeking to exploit the COVID-19 crisis to advance unfettered access to abortion-inducing drugs—found a friend in federal court.  In mid-July, Judge Theodore D. Chuang issued a preliminary injunction prohibiting the Food and Drug Administration (FDA) from enforcing certain hea...

The “No-Test Medication Abortion” Protocol: Experimenting with Women’s Health

A trend of mounting concern is occurring in abortion provision.  When elective induced abortion was legalized in the United States in 1973, one oft-cited motivation was to improve abortion’s safety, as it was frequently claimed that many women were injured and sometimes died from illegal abortion...